We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.9B
AUM Growth
-$468M
(-2.7%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
1,101
New
144
Increased
331
Reduced
453
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$319M |
| 2 |
Uber
UBER
|
+$90.8M |
| 3 |
Tyson Foods
TSN
|
+$81.8M |
| 4 |
Archer Daniels Midland
ADM
|
+$81.5M |
| 5 |
Travelers Companies
TRV
|
+$81.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$106M |
| 2 |
Lockheed Martin
LMT
|
+$88.6M |
| 3 |
Ross Stores
ROST
|
+$77.9M |
| 4 |
Hilton Worldwide
HLT
|
+$69.3M |
| 5 |
Cigna
CI
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Financials | 12.87% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
351
Altria Group
MO
$125B
| $5.69M | 0.03% |
135,398
-2,405,112
| -95% | -$106M |
|
|
MRO
352
DELISTED
Marathon Oil Corporation
MRO
| $5.69M | 0.03% |
212,810
-62,996
| -23% | -$1.63M |
|
353
Jazz Pharmaceuticals
JAZZ
$16.1B
| $5.66M | 0.03% |
43,757
-5,530
| -11% | -$737K |
|
354
Argan
AGX
$6.9B
| $5.64M | 0.03% |
123,809
-16,464
| -12% | -$680K |
|
355
Credo Technology Group
CRDO
$33.1B
| $5.62M | 0.03% |
368,471
+89
| +0% | +$1.4K |
|
|
BLUE
356
DELISTED
bluebird bio
BLUE
| $5.6M | 0.03% |
92,079
-12,467
| -12% | -$876K |
|
|
TSE
357
DELISTED
Trinseo
TSE
| $5.58M | 0.03% |
682,559
+70,501
| +12% | +$894K |
|
358
Crane NXT
CXT
$2.99B
| $5.57M | 0.03% |
100,191
+20,359
| +26% | +$1.18M |
|
359
Duolingo
DUOL
$6.53B
| $5.56M | 0.03% |
33,511
+14,649
| +78% | +$2.15M |
|
360
NETGEAR
NTGR
$612M
| $5.54M | 0.03% |
440,030
+175,288
| +66% | +$2.32M |
|
|
DNB
361
DELISTED
Dun & Bradstreet
DNB
| $5.51M | 0.03% |
551,283
-177,763
| -24% | -$1.96M |
|
362
Benchmark Electronics
BHE
$2.66B
| $5.39M | 0.03% |
222,367
-2,949
| -1% | -$74.9K |
|
363
REX American Resources
REX
$1.39B
| $5.39M | 0.03% |
264,740
-63,986
| -19% | -$1.2M |
|
|
BPMC
364
DELISTED
Blueprint Medicines
BPMC
| $5.37M | 0.03% |
107,023
-4,508
| -4% | -$241K |
|
365
LendingTree
TREE
$551M
| $5.35M | 0.03% |
345,292
+2,952
| +0.9% | +$59.8K |
|
366
KLA
KLAC
$222B
| $5.34M | 0.03% |
+116,450
| New | +$5.58M |
|
367
Herc Holdings
HRI
$4.78B
| $5.33M | 0.03% |
44,812
-8,934
| -17% | -$1.17M |
|
368
Usana Health Sciences
USNA
$419M
| $5.31M | 0.03% |
90,659
+2,168
| +2% | +$136K |
|
369
Helios Technologies
HLIO
$2.47B
| $5.31M | 0.03% |
95,694
+20,485
| +27% | +$1.22M |
|
370
Scansource
SCSC
$1.17B
| $5.26M | 0.03% |
173,409
+16,323
| +10% | +$490K |
|
371
Cerence
CRNC
$359M
| $5.24M | 0.03% |
257,411
-335,378
| -57% | -$8.43M |
|
372
Pulmonx
LUNG
$52.8M
| $5.22M | 0.03% |
505,379
-175,166
| -26% | -$2.03M |
|
373
AngioDynamics
ANGO
$605M
| $5.22M | 0.03% |
713,899
+274,210
| +62% | +$2.28M |
|
374
Inspire Medical Systems
INSP
$1.47B
| $5.07M | 0.03% |
25,559
-3,585
| -12% | -$904K |
|
375
Fate Therapeutics
FATE
$275M
| $5.06M | 0.03% |
2,389,123
+54,005
| +2% | +$179K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2023 Portfolio in Review
As of Q3 2023, Jacobs Levy Equity Management held 1,101 positions worth $16.9B, down 2.7% from $17.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2023 filing shows 144 new, 331 increased, 453 reduced and 149 closed positions. Its largest new stake was Tyson Foods: 1,536,421 shares worth $77.6M. The largest sale was Altria Group, an estimated $106M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2023 buy was Tyson Foods: 1,536,421 shares worth $77.6M.
- Jacobs Levy Equity Management added most to NVIDIA in Q3 2023, an estimated $319M increase.
- Jacobs Levy Equity Management's biggest Q3 2023 reduction was Altria Group, cutting an estimated $106M.
- Jacobs Levy Equity Management fully exited Hilton Worldwide in Q3 2023, selling an estimated $69.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $16.9B portfolio in Q3 2023.
- Jacobs Levy Equity Management opened 144 new positions and closed 149 in Q3 2023.
- Jacobs Levy Equity Management's portfolio value fell 2.7% quarter-over-quarter to $16.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.